Produktname:Potassium thiocyanate

IUPAC Name:

CAS:333-20-0
Molekulare Formel:CKNS
Reinheit:98%
Katalognummer:CM000375
Molekulargewicht:97.18

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM000375-500g 1-2 Weeks ǕƱ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:333-20-0
Molekulare Formel:CKNS
Schmelzpunkt:-
SMILES-Code:[S-]C#N.[K+]
Dichte:
Katalognummer:CM000375
Molekulargewicht:97.18
Siedepunkt:
Mdl-Nr.:MFCD00011413
Lagerung:

Column Infos

Crinecerfont
The New England Journal of Medicine publishes the primary CAHtalyst™ Adult Phase 3 study results of Crinecerfont for the treatment of congenital adrenal hyperplasia (CAH). Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) is a rare genetic disorder, affected by a lack of cortisol and/or aldosterone. Corticotropin-releasing factor type 1 receptor (CRF1) antagonism is shown to clinically decrease ACTH production and adrenal androgen levels.
Neurocrine's Crinecerfont is an investigational, selective CRF1 antagonist being developed to reduce and control excess adrenocorticotropic hormone (ACTH) and adrenal androgens. The phase 3 study meets primary and important key secondary endpoints, including a significant reduction in androstenedione levels and lowering glucocorticoid dosing.